Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies
Abstract
SARS-CoV-2 infections elicit a humoral immune response capable of neutralising the virus. However, multiple variants have emerged with mutations in the spike protein amongst others, the key target of neutralising antibodies. We evaluated the neutralising efficacy of 89 serum samples from patients, infected with SARS-CoV-2 in the beginning of 2020, against two virus variants isolated from acutely infected patients and harbouring spike protein...
Paper Details
Title
Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies
Published Date
Oct 4, 2021
Journal
Volume
57
Issue
6
Pages
502 - 509
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History